济南做个包皮手术多少钱呀济南龟头敏感该怎么样治,济南前列腺可以切除吗,济南手淫过渡导致时间短怎么办,济南男科医院泌尿外科,济南阳痿治疗的好方法,济南勃起没感觉是什么原因,济南前列腺是怎么得的

SAN FRANCISCO, Dec. 2 (Xinhua) -- About one in 10 mobile phone subscribers in the United States is now using an Apple iPhone, said a new survey released on Friday.Latest survey results from research firm comScore showed that for the three-month period ending in October, Apple remained the No. 4 handset maker in the U.S. with its share of mobile subscribers rising to 10.8 percent from 9.5 percent in the previous three months.Among the top five mobile phone brands in the U.S. market, Apple is the only one that saw its market share increase in the quarter, according to the survey.Samsung was still the top handset manufacturer with 25.5 percent of U.S. mobile subscribers, followed by LG and Motorola taking the second and third place with 20.6 percent and 13.6 percent of share respectively.Research in Motion (RIM), maker of Blackberry, ranked No. 5 with a share of 6.6 percent.Except Apple, market shares of the other four brands remained unchanged or dropped from the previous quarter.Apple's gain in the quarter might be driven by the introduction of new model iPhone 4S which went on sale on Oct. 14, and the addition of Sprint as a carrier in the U.S. market, some analysts said.The survey by comScore, which involved more than 30,000 U.S. mobile subscribers, found that 234 million Americans age 13 and older used mobile devices by the end of October.

LOS ANGELES, Oct. 3 (Xinhua) -- An organizer of the World Stem Cell Summit says one of the key problems medical researchers face these days is how to apply their findings in the real world."How do you take the phenomenal scientific research going on in labs and translate it into medical treatments,?" said Bernie Siegel, the founder and co-chair of the summit and executive director of the Genetic Policy Institute, which organized the event."It's a big job to do this, and more than just the science," Siegel said, noting that in a growing field now moving beyond basic lab research, the aim is to connect the people who do the work with those who finance it.The three-day summit, which opened Monday in Pasadena, features more than 150 top international speakers and 50 hours of programming with leaders from science, pharmaceutics, business, policy, ethics, law and other fields.The cell therapy industry, a "nascent" field, has emerged to be a potentially multi-billion business with unlimited potential, Siegel said.Stephen Dalton, a University of Georgia professor, reported that one of the biggest developments in stem cell research in the past year was the realization that cells can be transdifferentiated from one state to another without returning to a pluripotent state.Dalton said the principle was previously supported by a few isolated examples but it was not until 2010 that the idea was widely accepted.Mark Sussman, a professor from San Diego State University, called the identification of lung stem cells from human tissue samples capable of regenerating the highly complex and specialized structures of mature lungs a breakthrough in lung biology and regenerative medicine.He said results presented by the Anversa group in the New England Journal of Medicine demonstrate that human lung stem cells can be expanded in vitro and also retain the capacity to integrate into adult tissue upon introduction into mice.The study, Sussman said, has opened up an entirely new field of possibilities for lung regeneration and potential therapeutic applications for many conditions where treatment options are either very limited or nonexistent.

ADDIS ABABA, Dec. 2 (Xinhua) -- Xie Xiaoyan, the newly appointed Chinese ambassador to Ethiopia and the African Union (AU) on Friday presented his letter of credence to Jean Ping, chairperson of the AU Commission (AUC) at his office in Addis Ababa, Ethiopia.After presenting the credential letter to Ping at the AU headquarters, Ambassador Xie held talks with the AUC chief on the relations and cooperation between China and the union of 54 member countries.The Chinese government has constructed a state-of-the-art office complex and conference hall for the AU with an outlay of around 125 million U.S. dollars, a project that demonstrates the friendship between China and Africa.

KATHMANDU, Oct. 30 (Xinhua) -- "One of the major problems of death due to breast cancer in Nepal is poverty and untimely diagnosis," said Dr. Abish Adhikari Oncologist at the Bir Hospital in Nepali capital Kathmandu in an exclusive interview with Xinhua on Sunday.Adhikari said that the other reason why breast cancer leads to death of women is "women are not decision makers in their houses"."Many people who come here do not want to treat their wives or daughters because of the expenses as they are poor and it is really expensive here to treat cancer," Adhikari said.According to the Nepal Cancer Relief Society, of all cancer cases among the Nepali women and teenage girls as well, 60 percent is of breast cancer.Unverified rough data of the breast cancer patients in Nepal are above 50,000.Adhikari added that women are shy to talk about the problems of breast. They do not go to hospitals for the check up until they are bedridden and at the time they reach hospital they are mostly in the advanced stage.The major causes behind the breast cancer in Nepal are heredity, late pregnancy, consumption of alcohol and smoking. However, unawareness about it remains another major problem that leadind to death of many women in Nepal.Moreover, the rural women in Nepal are unaware about breast cancer, and if they are having some problem, they tend to hide it.Talking to Xinhua, Sajani Manandhar, General Secretary of Richa Bajimaya Memorial Foundation, a cancer awareness raising group said that the major cause of the preventable cancer in Nepal is unawareness.Also a nurse by profession, she said that no one bothers about mammography or regular checkup but are diagnosed at the very late stage.There are less than five hospitals that provide mammography service in the country.Roshani Chitrakar, 48 who is in advanced stage of cancer said that she did not told anyone while she found something unusual in her breast because it was not painful."I took it normally, but when I thought it might be a cancer and told my family and I was already in the advanced stage," she said.Her daughter, Roji Manandhar, said that the doctor has already told that she will not be living long. She is having difficulty even to eat currently.Another cancer patient, 67 years old farmer, Nakkali Nahakhusi said that she told her husband when she found her breast unusual. Her husband, former armyman, immediately took her to the hospital when she told about the problem.Now, she is already cured, and said with smilingly that the god of death did not want to take me away.She said that awareness should be raised because cancer is curable at the early stage.

BEIJING, Oct. 13 (Xinhuanet) -- A new study finds that ginger may decrease the risk of colon cancer through diminishing the inflammation in the gut, according to media reports Thursday.Prior researches have found that chronicle inflammation in the gut is related to colon cancer, suggesting easing inflammation in intestines might reduce the risk of the cancer, said Suzanna M. Zick, lead author of the study published online in Cancer Prevention Research. Zick, also a naturopathic physician and research associate professor at University of Michigan Medical Center, and her colleagues, assigned 30 volunteers to take pills containing two grams of either placebo powder or ginger root extract, equivalent to about two tablespoons of ground-up raw ginger root.And they recorded the inflammations in the participants' intestines before and after the test period.The researchers found that participants taking ginger pills had 28 percent less inflammation in their intestines after the test. But no difference was found in those who took placebo.The findings are promising, but the researchers are not yet recommending people start taking more ginger at meal times. The study only involved 30 participants, so it is just a preliminary study. Zick said they hope to launch a larger study in the future, according to USA Today.